The Silent Threat: Atrial Fibrillation (AFIB)

Atrial Fibrillation (AFIB) is a common heart rhythm disorder characterized by irregular and rapid heartbeat. This condition significantly increases the risk of stroke, heart failure, and other serious complications. Early detection and management are crucial for preventing adverse outcomes.

The High Cost of AFIB: A Silent Epidemic

The impact of AFIB extends beyond physical symptoms. It can lead to reduced quality of life, increased healthcare costs, and a significant burden on patients and healthcare systems. The need for effective risk assessment tools to identify individuals at risk of developing AFIB is paramount.

Kribado: Your Shield Against AFIB

Kribado is a cutting-edge risk stratification and behavior setting device designed to combat the challenges of AFIB management. By accurately assessing patients’ risk for developing AFIB, Kribado empowers healthcare providers to implement preventive measures and personalized treatment plans.

This innovative solution offers a non-invasive screening process that delivers instant risk scores, enabling efficient patient triage and resource allocation. Kribado’s user-friendly interface and streamlined data collection ensure accurate and reliable results.

Indigital Technologies: Your Partner in Heart Health

Indigital Technologies is a leading pharmaceutical business growth expert with a proven track record of success. Our 9-year journey has involved collaborating with 653 pharmaceutical brands across 8 countries, generating over 9700 crores in revenue.

We are committed to developing innovative solutions that address critical healthcare challenges. With over 200 COAs and expertise across 12 therapeutic areas, Kribado represents our dedication to improving patient lives.